EODData

MEMBERSHIP REGISTER LOG IN

SHG, 688319: Chengdu Olymvax Biopharmaceuticals Inc. A

26 Aug 2025
LAST:

30.25

CHANGE:
 2.42		OPEN:
32.45		HIGH:
33.06		ASK:
0.00		VOLUME:
13.92M
CHG(%):
7.41		PREV:
32.67		LOW:
30.20		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Aug 2532.4533.0630.2030.2513.92M
25 Aug 2531.7833.1931.1532.679.83M
22 Aug 2532.7034.2032.2133.1711.66M
21 Aug 2533.9034.6832.6232.7013.55M
20 Aug 2531.0033.8530.1133.1117.16M
19 Aug 2527.6933.2327.2331.2127.56M
18 Aug 2523.9928.0023.8727.6916.94M
15 Aug 2524.4924.4923.2023.999.93M
14 Aug 2524.2024.7323.7524.3014.58M
13 Aug 2520.4824.2620.3024.0217.21M

COMPANY PROFILE

Name:Chengdu Olymvax Biopharmaceuticals Inc. A
About:Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use. It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. The company also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and staphylococcus aureus, which is in Phase 3 clinical trial. In addition, it engages in technology promotion and application services business; biotechnology, R&D, and consulting. The company was founded in 2009 and is based in Chengdu, China.
Sector:Healthcare
Industry:Biotechnology
Address:No. 99 Tianxin Road, Chengdu, China, 611731
Website:https://www.olymvax.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:331.70
PtB:14.64
PtS:22.24
EBITDA:72.93M
Shares:405.93M
Market Cap:12.28B

TECHNICAL INDICATORS

MA5:32.38
MA10:29.31
MA20:25.21
MA50:20.45
MA100:18.20
MA200:15.10
STO9:58.56
STO14:69.41
RSI14:72.43
WPR14:-22.51
MTM14:9.18
ROC14:0.44
ATR:2.31
Week High:34.68
Week Low:27.23
Month High:34.68
Month Low:19.99
Year High:34.68
Year Low:8.11
Volatility:10.14